Japan Orthobiologics Market Outlook to 2021

Market: Medicine

Japan, 59 pages report, published by GlobalData

Keywords : Orthopedic Devices, Orthopedic, Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Companies, Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Smith & Nephew Plc, Arthrex, Inc., DJO Finance LLC, Otto Bock HealthCare GmbH, Ossur hf., BSN medical GmbH, NuVasive, Inc., 3M Health Care Ltd., Sanofi, Globus Medical, Inc., Paradigm Spine, LLC, B. Braun Melsungen AG, Spinal Kinetics Inc., Orliman, S.L.U., Baxter International Inc., Thuasne SA, RO+TEN srl, Amplitude SAS, Tornier N.V., Trulife, Ltd, Seikagaku Corporation, e-life International Co., Ltd., Shandong Weigao Orthopaedic Device Co., Ltd., Corin Group Plc, Naton Medical Group, Waldemar LINK GmbH & Co. KG, Beijing AKEC Medical Co., Ltd., Bonovo Orthopedics, Inc., Beijing Chunlizhengda Medical Instruments Co., Ltd, Xiamen Double Engine Medical Material Co., Ltd., S. H. Pitkar Orthotools Pvt. Ltd., Heraeus Medical GmbH, KYOCERA Medical Corporation, Corentec Co., Ltd., Cellumed Co. Ltd., Gs Medical Co.,Ltd., Seoul Brace, Otis biotech company, Medyssey Co., Ltd., Baumer S.A.

Report ThumbnailSeptember-2015
Japan Orthobiologics Market Outlook to 2021

Summary

GlobalData’s new report, "Japan Orthobiologics Market Outlook to 2021", provides key market data on the Japan Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the Japan Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
  • 1.2 List of Figures
  • Figure 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 8
  • Figure 2: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 10
  • Figure 3: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 12
  • Figure 4: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 14
  • Figure 5: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 16
  • Figure 6: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 18
  • Figure 7: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 20
  • Figure 8: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 22
  • Figure 9: Orthobiologics Market, Japan, Volume (Units), Historic, 2007-2014 24
  • Figure 10: Orthobiologics Market, Japan, Volume (Units), Forecast, 2014-2021 26
  • Figure 11: Bone Grafts and Substitutes Market, Japan, Volume (Units), Historic, 2007-2014 28
  • Figure 12: Bone Growth Stimulators Market, Japan, Volume (Units), Historic, 2007-2014 30
  • Figure 13: Viscosupplementation Market, Japan, Volume (Units), Historic, 2007-2014 32
  • Figure 14: Bone Grafts and Substitutes Market, Japan, Volume (Units), Forecast, 2014-2021 34
  • Figure 15: Bone Growth Stimulators Market, Japan, Volume (Units), Forecast, 2014-2021 36
  • Figure 16: Viscosupplementation Market, Japan, Volume (Units), Forecast, 2014-2021 38
  • Figure 17: Orthobiologics Market, Japan, Company Share (%) 2014 43
  • Figure 18: GlobalData Epidemiology-Based Forecasting Model 56
  • Figure 19: GlobalData Capital Equipment-Based Forecasting Model 57
  • Figure 20: Primary Interviews by Participant Type (%) 58
  • 1.1 List of Tables
  • Table 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 9
  • Table 2: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 11
  • Table 3: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 13
  • Table 4: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 15
  • Table 5: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 17
  • Table 6: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 19
  • Table 7: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 21
  • Table 8: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 23
  • Table 9: Orthobiologics Market, Japan, Volume (Units), Historic, 2007-2014 25
  • Table 10: Orthobiologics Market, Japan, Volume (Units), Forecast, 2014-2021 27
  • Table 11: Bone Grafts and Substitutes Market, Japan, Volume (Units), Historic, 2007-2014 29
  • Table 12: Bone Growth Stimulators Market, Japan, Volume (Units), Historic, 2007-2014 31
  • Table 13: Viscosupplementation Market, Japan, Volume (Units), Historic, 2007-2014 33
  • Table 14: Bone Grafts and Substitutes Market, Japan, Volume (Units), Forecast, 2014-2021 35
  • Table 15: Bone Growth Stimulators Market, Japan, Volume (Units), Forecast, 2014-2021 37
  • Table 16: Viscosupplementation Market, Japan, Volume (Units), Forecast, 2014-2021 39
  • Table 17: Orthobiologics Market, Japan, Average Price ($) Historic, 2007-2014 40
  • Table 18: Orthobiologics Market, Japan, Average Price ($), Forecast, 2014-2021 41
  • Table 19: Orthobiologics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 42
  • Table 20: Orthobiologics Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 44
  • Table 21: Orthobiologics Market Pipeline Products 47
  • Table 22: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 54
  • 1 Table of Contents
  • 1 Table of Contents 2
  • 1.1 List of Tables 3
  • 1.2 List of Figures 4
  • 2 Introduction 5
  • 2.1 What Is This Report About? 5
  • 2.2 Orthobiologics Market Segmentation 5
  • 2.3 Definitions of Markets Covered in the Report 6
  • 3 Orthobiologics Market, Japan 8
  • 3.1 Orthobiologics Market, Japan, Revenue ($m), 2007-2014 8
  • 3.2 Orthobiologics Market, Japan, Revenue ($m), 2014-2021 10
  • 3.2.1 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2007-2014 12
  • 3.2.2 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2007-2014 14
  • 3.2.3 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2007-2014 16
  • 3.2.4 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2014-2021 18
  • 3.2.5 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2014-2021 20
  • 3.2.6 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2014-2021 22
  • 3.3 Orthobiologics Market, Japan, Volume (Units), 2007-2014 24
  • 3.4 Orthobiologics Market, Japan, Volume (Units), 2014-2021 26
  • 3.4.1 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2007-2014 28
  • 3.4.2 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2007-2014 30
  • 3.4.3 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2007-2014 32
  • 3.4.4 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2014-2021 34
  • 3.4.5 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2014-2021 36
  • 3.4.6 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2014-2021 38
  • 3.5 Orthobiologics Market, Japan, Average Price ($), 2007-2021 40
  • 3.6 Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2013-2014 42
  • 3.7 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2014 43
  • 4 Overview of Key Companies in Japan, Orthobiologics Market 45
  • 4.1 Seikagaku Corporation 45
  • 4.1.1 Company Overview 45
  • 4.2 DePuy Companies 45
  • 4.2.1 Company Overview 45
  • 4.3 Medtronic plc 45
  • 4.3.1 Company Overview 45
  • 4.4 Sanofi 46
  • 4.4.1 Company Overview 46
  • 4.5 Stryker Corporation 46
  • 4.5.1 Company Overview 46
  • 4.6 Arthrex, Inc. 46
  • 4.6.1 Company Overview 46
  • 5 Orthobiologics Market Pipeline Products 47
  • 6 Appendix 51
  • 6.1 Research Methodology 52
  • 6.1.1 Coverage 52
  • 6.1.2 Secondary Research 52
  • 6.1.3 Primary Research 53
  • 6.1.4 Market Modeling and Forecasting 54
  • 6.1.5 Company Share Analysis 57
  • 6.1.6 Distribution Share Analysis 58
  • 6.2 Expert Panel 59
  • 6.3 GlobalData Consulting 59
  • 6.4 Contact Us 59
  • 6.5 Disclaimer 59

Please select a license type

Share

Related Products

GlobalDataJapan Orthobiologics Market Outlook to 2021Product ThumbnailJapan Orthobiologics Market Outlook to 2021, Industry ReportProduct #: 135547
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved